- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-6-1-mer
- Ligands
- 4 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.3: 19 residues within 4Å:- Chain A: D.609, R.635, R.638
- Chain B: D.478, G.480, P.519, P.520, G.521, C.522, G.523, K.524, T.525, L.526, Q.578, I.656, G.684, A.685, T.688
- Ligands: MG.5
17 PLIP interactions:13 interactions with chain B, 4 interactions with chain A- Hydrogen bonds: B:G.480, B:G.480, B:P.519, B:G.521, B:C.522, B:G.523, B:K.524, B:T.525, B:L.526, B:Q.578, B:T.688
- Salt bridges: B:K.524, B:K.524, A:R.635, A:R.635, A:R.635, A:R.638
ATP.6: 21 residues within 4Å:- Chain B: D.333, R.359, R.362
- Chain C: D.205, I.206, G.207, P.246, P.247, G.248, T.249, G.250, K.251, T.252, L.253, E.305, N.348, I.380, H.384, G.408, A.409
- Ligands: MG.9
16 PLIP interactions:12 interactions with chain C, 4 interactions with chain B- Hydrogen bonds: C:G.207, C:G.248, C:T.249, C:T.249, C:G.250, C:K.251, C:T.252, C:L.253, C:N.348, C:N.348
- Salt bridges: C:K.251, C:K.251, B:R.359, B:R.359, B:R.359, B:R.362
ATP.7: 21 residues within 4Å:- Chain B: D.609, R.635, R.638
- Chain C: D.478, I.479, G.480, P.520, G.521, C.522, G.523, K.524, T.525, L.526, Q.578, N.624, I.656, N.660, G.684, A.685, T.688
- Ligands: MG.8
16 PLIP interactions:12 interactions with chain C, 4 interactions with chain B- Hydrogen bonds: C:G.480, C:G.480, C:G.521, C:C.522, C:G.523, C:K.524, C:T.525, C:L.526, C:Q.578, C:N.624
- Salt bridges: C:K.524, C:K.524, B:R.635, B:R.635, B:R.635, B:R.638
ATP.10: 20 residues within 4Å:- Chain C: D.333, R.359, R.362
- Chain D: D.205, I.206, G.207, P.247, G.248, T.249, G.250, K.251, T.252, L.253, E.305, N.348, I.380, H.384, G.408, A.409
- Ligands: MG.13
18 PLIP interactions:14 interactions with chain D, 4 interactions with chain C- Hydrogen bonds: D:G.207, D:G.207, D:G.248, D:T.249, D:T.249, D:G.250, D:K.251, D:T.252, D:L.253, D:N.348, D:N.348
- Salt bridges: D:K.251, D:K.251, D:R.256, C:R.359, C:R.359, C:R.359, C:R.362
ATP.11: 19 residues within 4Å:- Chain C: R.635, R.638
- Chain D: D.478, I.479, G.480, P.520, G.521, C.522, G.523, K.524, T.525, L.526, Q.578, N.624, I.656, G.684, A.685, T.688
- Ligands: MG.12
19 PLIP interactions:15 interactions with chain D, 4 interactions with chain C- Hydrogen bonds: D:G.480, D:G.480, D:P.519, D:G.521, D:C.522, D:G.523, D:G.523, D:K.524, D:T.525, D:L.526, D:Q.578, D:N.624, D:T.688
- Salt bridges: D:K.524, D:K.524, C:R.635, C:R.635, C:R.635, C:R.638
ATP.14: 20 residues within 4Å:- Chain D: D.333, R.359, R.362
- Chain E: D.205, I.206, G.207, P.247, G.248, T.249, G.250, K.251, T.252, L.253, R.256, N.348, I.380, H.384, G.408, A.409
- Ligands: MG.17
17 PLIP interactions:13 interactions with chain E, 4 interactions with chain D- Hydrogen bonds: E:G.207, E:G.248, E:T.249, E:T.249, E:T.249, E:G.250, E:K.251, E:T.252, E:L.253, E:N.348
- Salt bridges: E:K.251, E:K.251, E:R.256, D:R.359, D:R.359, D:R.359, D:R.362
ATP.15: 20 residues within 4Å:- Chain D: R.635, R.638
- Chain E: D.478, I.479, G.480, P.520, G.521, C.522, G.523, K.524, T.525, L.526, Q.578, N.624, I.656, N.660, G.684, A.685, T.688
- Ligands: MG.16
19 PLIP interactions:15 interactions with chain E, 4 interactions with chain D- Hydrogen bonds: E:G.480, E:G.480, E:P.519, E:G.521, E:C.522, E:G.523, E:K.524, E:T.525, E:T.525, E:L.526, E:Q.578, E:N.624, E:T.688
- Salt bridges: E:K.524, E:K.524, D:R.635, D:R.635, D:R.635, D:R.638
ATP.18: 18 residues within 4Å:- Chain E: F.360
- Chain F: D.205, I.206, G.207, P.247, G.248, T.249, G.250, K.251, T.252, L.253, E.305, N.348, I.380, H.384, G.408, A.409
- Ligands: MG.20
14 PLIP interactions:14 interactions with chain F- Hydrogen bonds: F:G.207, F:G.207, F:G.248, F:T.249, F:T.249, F:G.250, F:K.251, F:T.252, F:L.253, F:E.305, F:E.305, F:N.348
- Salt bridges: F:K.251, F:K.251
- 8 x MG: MAGNESIUM ION(Non-covalent)
MG.5: 3 residues within 4Å:- Chain A: D.609
- Chain B: T.525
- Ligands: ATP.3
No protein-ligand interaction detected (PLIP)MG.8: 2 residues within 4Å:- Chain C: T.525
- Ligands: ATP.7
1 PLIP interactions:1 interactions with chain C- Metal complexes: C:T.525
MG.9: 3 residues within 4Å:- Chain C: T.252, D.304
- Ligands: ATP.6
1 PLIP interactions:1 interactions with chain C- Metal complexes: C:T.252
MG.12: 3 residues within 4Å:- Chain D: T.525, D.577
- Ligands: ATP.11
1 PLIP interactions:1 interactions with chain D- Metal complexes: D:T.525
MG.13: 3 residues within 4Å:- Chain C: R.362
- Chain D: T.252
- Ligands: ATP.10
1 PLIP interactions:1 interactions with chain D- Metal complexes: D:T.252
MG.16: 4 residues within 4Å:- Chain E: T.525, D.577, Q.578
- Ligands: ATP.15
1 PLIP interactions:1 interactions with chain E- Metal complexes: E:T.525
MG.17: 3 residues within 4Å:- Chain D: R.362
- Chain E: T.252
- Ligands: ATP.14
1 PLIP interactions:1 interactions with chain E- Metal complexes: E:T.252
MG.20: 3 residues within 4Å:- Chain F: T.252, D.304
- Ligands: ATP.18
1 PLIP interactions:1 interactions with chain F- Metal complexes: F:T.252
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pan, M. et al., Mechanistic insight into substrate processing and allosteric inhibition of human p97. Nat.Struct.Mol.Biol. (2021)
- Release Date
- 2021-09-15
- Peptides
- Transitional endoplasmic reticulum ATPase: ABCDEF
polyubiquitinated Ub-Eos: G - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
G
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-6-1-mer
- Ligands
- 4 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 8 x MG: MAGNESIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pan, M. et al., Mechanistic insight into substrate processing and allosteric inhibition of human p97. Nat.Struct.Mol.Biol. (2021)
- Release Date
- 2021-09-15
- Peptides
- Transitional endoplasmic reticulum ATPase: ABCDEF
polyubiquitinated Ub-Eos: G - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
G